France-headquartered global biopharmaceutical company, Sanofi, priced a dual-tranche €1.5bn (US$1.64bn) notes issue on March 30. The transaction was split into €850m of fixed rate notes, due April 2025, paying an annual…
France-headquartered global biopharmaceutical company, Sanofi, priced a dual-tranche €1.5bn (US$1.64bn) notes issue on March 30. The transaction was split into €850m of fixed rate notes, due April 2025, paying an annual…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference